A new fluorescenttargeting tracer contrasts dual tracers in sentinel lymph node biopsy of breast cancer
Future Oncology · 2024
DOI: 10.2217/fon-2021-1152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Oncology, 2024. Verfasst von Shuang Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery, Kailuan General Hospital, Tangshan, Heibei, 063000, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Sentinel Lymph Node. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Purpose
To explore the clinical application value of indocyanine green (ICG)-rituximab in sentinel lymph node biopsy.
Methods
This study included 156 patients with primary breast cancer: 50 patients were enrolled in dose-climbing test, and 106 patients were enrolled in verification test. This was to compare the consistency of ICG-rituximab and combined method in the detected lymph nodes.
Results
According to the verification test, the imaging rate of ICG-rituximab was 97.3%. Compared with the combined method, the concordance rate of fluorescence method was 0.991 (28 + 78/107; p < 0.001).
Conclusion
For ICG-rituximab as a fluorescent targeting tracer, the optimal imaging dose of ICG 93.75 μg/rituximab 375 μg can significantly reduce the imaging of secondary lymph nodes. Compared with the combined method, it has a higher concordance rate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- General Surgery, Kailuan General Hospital, Tangshan, Heibei, 063000, China.
- Department of Breast Surgery, Yuncheng Central Hospital, Yuncheng, 044000, China.
- Breast Cancer Center, Shandong Cancer Hospital & Institute, Shandong First Medical University & Shandong Academy of Medical Science, Jinan, 250000, China.
ORCID-Profile: Shuang Wu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wu, S., Li, P., Zhang, Q., Sun, X., Cong, B., & Wang, Y. (2024). A new fluorescenttargeting tracer contrasts dual tracers in sentinel lymph node biopsy of breast cancer. Future Oncology. https://doi.org/10.2217/fon-2021-1152
Vancouver
Wu S, Li P, Zhang Q, Sun X, Cong B, Wang Y. A new fluorescenttargeting tracer contrasts dual tracers in sentinel lymph node biopsy of breast cancer. Future Oncology. 2024. doi:10.2217/fon-2021-1152
BibTeX
@article{Wu2024,
author = {Wu, Shuang and Li, Panpan and Zhang, Qingsong and Sun, Xiao and Cong, Binbin and Wang, Yongsheng},
title = {A new fluorescenttargeting tracer contrasts dual tracers in sentinel lymph node biopsy of breast cancer},
journal = {Future Oncology},
year = {2024},
doi = {10.2217/fon-2021-1152}
}
EUVIMED